AI-Powered ECG reading aims to catch heart failure sooner

NCT ID NCT07113223

First seen Jun 25, 2026 · Last updated Jun 25, 2026

Summary

This study tests whether an artificial intelligence system called Willem™ can help primary care doctors detect heart failure more accurately by analyzing electrocardiograms (ECGs). About 1,968 adults with suspected heart failure or high cardiovascular risk will be randomly assigned to get either AI-assisted or standard ECG interpretation. The goal is to see if AI improves diagnosis and reduces unnecessary tests.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital General Universitario Gregorio Marañón

    RECRUITING

    Madrid, Spain

    Contact Email: •••••@•••••

  • Hospital Universitario 12 de Octubre

    RECRUITING

    Madrid, Spain

    Contact Email: •••••@•••••

  • Hospital Universitario Marqués de Valdecilla

    RECRUITING

    Santander, Spain

    Contact Email: •••••@•••••

  • Primary Care: Gerencia Asistencial Atención Primaria Madrid

    RECRUITING

    Madrid, Spain

    Contact Email: •••••@•••••

  • Region Stockholm

    RECRUITING

    Stockholm, Sweden

    Contact Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Willem™ platform (AI-assisted ECG analysis device)

What this could lead to

If successful, this could make heart failure detection faster and more accurate in primary care, potentially leading to earlier treatment and better patient outcomes.

What could go wrong

This is a pragmatic trial, but AI tools may not work equally well in all settings or populations. The study is still recruiting, and results are not yet available.

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.